Serving leading biopharmaceutical companies globally:

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Patent: 9,458,089

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,458,089

Title:	Phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering active agents
Abstract:	The present invention relates to particular phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering biologically active agents to a target. These compounds are well suited for forming non-covalent mixtures with active agents for oral, intracolonic, pulmonary, and other routes of administration to animals.
Inventor(s):	Mustata; Gabriela (Roseland, NJ), Pan; Dahua (Roseland, NJ), Gschneidner; David (Roseland, NJ)
Assignee:	Emisphere Technologies, Inc. (Roseland, NJ)
Application Number:	14/423,319
Patent Claims:	see list of patent claims

Details for Patent 9,458,089

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	004	2015-01-23	Start Trial	Emisphere Technologies, Inc. (Roseland, NJ)	2032-08-23	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	003	2015-01-23	Start Trial	Emisphere Technologies, Inc. (Roseland, NJ)	2032-08-23	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	002	2015-01-23	Start Trial	Emisphere Technologies, Inc. (Roseland, NJ)	2032-08-23	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	001	2015-01-23	Start Trial	Emisphere Technologies, Inc. (Roseland, NJ)	2032-08-23	RX	Orphan	search
Amgen	NEUPOGEN	filgrastim	SYRINGE	103353	004	1991-02-20	Start Trial	Emisphere Technologies, Inc. (Roseland, NJ)	2032-08-23	RX		search
Amgen	NEUPOGEN	filgrastim	SYRINGE	103353	003	1991-02-20	Start Trial	Emisphere Technologies, Inc. (Roseland, NJ)	2032-08-23	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 9,458,089

Subscribe to access the full database, or Start Trial
Country	Patent Number	Publication Date
World Intellectual Property Organization (WIPO)	2014031874	Feb 27, 2014
United States of America	2015321993	Nov 12, 2015
Mexico	2015002373	Sep 25, 2015
Japan	2015527373	Sep 17, 2015
Japan	6251743	Dec 20, 2017
Hong Kong	1212319	Jun 10, 2016
>Country	>Patent Number	>Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys

Express Scripts

Johnson and Johnson

Harvard Business School

Dow

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.